127 related articles for article (PubMed ID: 21073813)
21. Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies.
Jones AW; Holmgren A
Forensic Sci Int; 2012 Oct; 222(1-3):118-23. PubMed ID: 22673707
[TBL] [Abstract][Full Text] [Related]
22. Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots.
Jantos R; Vermeeren A; Sabljic D; Ramaekers JG; Skopp G
Int J Legal Med; 2013 Jan; 127(1):69-76. PubMed ID: 22532152
[TBL] [Abstract][Full Text] [Related]
23. The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone.
Aranko K; Luurila H; Backman JT; Neuvonen PJ; Olkkola KT
Br J Clin Pharmacol; 1994 Oct; 38(4):363-7. PubMed ID: 7833227
[TBL] [Abstract][Full Text] [Related]
24. Enantioselective determination of (R)-zopiclone and (S)-zopiclone (eszopiclone) in human hair by micropulverized extraction and chiral liquid chromatography/high resolution mass spectrometry.
Miyaguchi H; Kuwayama K
J Chromatogr A; 2017 Oct; 1519():55-63. PubMed ID: 28886938
[TBL] [Abstract][Full Text] [Related]
25. Can a simple clinical test detect impairment of zopiclone and alcohol? - A randomized controlled trial.
Hjelmeland K; Gustavsen I; Bernard JP; Mørland J
Forensic Sci Int; 2015 Mar; 248():129-33. PubMed ID: 25617762
[TBL] [Abstract][Full Text] [Related]
26. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS.
Kintz P; Villain M; Concheiro M; Cirimele V
Forensic Sci Int; 2005 Jun; 150(2-3):213-20. PubMed ID: 15944062
[TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacokinetics of zopiclone.
Fernandez C; Martin C; Gimenez F; Farinotti R
Clin Pharmacokinet; 1995 Dec; 29(6):431-41. PubMed ID: 8787948
[TBL] [Abstract][Full Text] [Related]
28. The excretion of zopiclone into breast milk.
Matheson I; Sande HA; Gaillot J
Br J Clin Pharmacol; 1990 Aug; 30(2):267-71. PubMed ID: 2206788
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous determination of zopiclone and its two major metabolites (N-oxide and N-desmethyl) in human biological fluids by reversed-phase high-performance liquid chromatography.
Le Liboux A; Frydman A; Gaillot J
J Chromatogr; 1987 Jun; 417(1):151-8. PubMed ID: 3624392
[TBL] [Abstract][Full Text] [Related]
30. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion.
Pounder DJ; Davies JI
Forensic Sci Int; 1994 May; 65(3):177-83. PubMed ID: 8039775
[TBL] [Abstract][Full Text] [Related]
31. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers.
Gustavsen I; Al-Sammurraie M; Mørland J; Bramness JG
Accid Anal Prev; 2009 May; 41(3):462-6. PubMed ID: 19393793
[TBL] [Abstract][Full Text] [Related]
32. Validation of a high-performance liquid chromatographic method for the enantiospecific quantitation of zopiclone in plasma.
Gebauer MG; Alderman CP
Biomed Chromatogr; 2002 Jun; 16(4):241-6. PubMed ID: 11933023
[TBL] [Abstract][Full Text] [Related]
33. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair.
Laloup M; Ramirez Fernandez Mdel M; De Boeck G; Wood M; Maes V; Samyn N
J Anal Toxicol; 2005 Oct; 29(7):616-26. PubMed ID: 16419390
[TBL] [Abstract][Full Text] [Related]
34. Identification and quantitation of zopiclone in biological matrices using gas chromatography-mass spectrometry (GC-MS).
Rohrig TP; Norton MC; Harryman LA
Methods Mol Biol; 2010; 603():527-33. PubMed ID: 20077105
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
Fernandez C; Maradeix V; Gimenez F; Thuillier A; Farinotti R
Drug Metab Dispos; 1993; 21(6):1125-8. PubMed ID: 7905394
[TBL] [Abstract][Full Text] [Related]
36. Chromatographic screening for zopiclone and metabolites in urine using liquid chromatography and liquid chromatography-mass spectrometry techniques.
Nordgren HK; Bodin K; Beck O
Ther Drug Monit; 2002 Jun; 24(3):410-6. PubMed ID: 12021634
[TBL] [Abstract][Full Text] [Related]
37. Interpretation of oxycodone concentrations in oral fluid.
Moore C; Kelley-Baker T; Lacey J
J Opioid Manag; 2012; 8(3):161-6. PubMed ID: 22798176
[TBL] [Abstract][Full Text] [Related]
38. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests.
Kuitunen T; Mattila MJ; Seppälä T; Aranko K; Mattila ME
Br J Clin Pharmacol; 1990 Sep; 30(3):453-61. PubMed ID: 2223424
[TBL] [Abstract][Full Text] [Related]
39. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone.
Jalava KM; Olkkola KT; Neuvonen PJ
Eur J Clin Pharmacol; 1996; 51(3-4):331-4. PubMed ID: 9010708
[TBL] [Abstract][Full Text] [Related]
40. In vivo saturation binding of GABA-A receptor ligands to estimate receptor occupancy using liquid chromatography/tandem mass spectrometry.
Hopkins SC; Brian Nofsinger J; Allen MS; Koch P; Varney MA
Biopharm Drug Dispos; 2009 Jan; 30(1):9-20. PubMed ID: 19152227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
